PDE5A and pulmonary arterial hypertension: Tadalafil (TDLF), a phosphodiesterase type 5 (PDE5) inhibitor primarily used for treating erectile dysfunction and pulmonary arterial hypertension (Lang et al., 2024), is not immune to these challenges.